Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Johnson and Johnson
Harvard Business School

Generated: November 23, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,264,446

« Back to Dashboard

Summary for Patent: 5,264,446

Title: Solid medicament formulations containing nifedipine, and processes for their preparation
Abstract:The invention is directed to the provision of solid pharmaceutical compositions (and methods for their preparation) containing nifidipine crystals with a specific surface area of 1.0 to 4.0 m.sup.2 /g., in admixture with a solid diluent. The said compositions overcome the deficiencies of prior art compositions containing nifidipine, which is known to have effect as a coronary vasodilator.
Inventor(s): Hegasy; Ahmed (Leverkusen, DE), Ramsch; Klaus-Dieter (Heerlen, NL)
Assignee: Bayer Aktiengesellschaft (Leverkusen, DE)
Application Number:07/892,439
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Use;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,264,446

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany3033919Sep 09, 1980

International Patent Family for Patent: 5,264,446

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina226377► Subscribe
Austria5761► Subscribe
Australia558331► Subscribe
Australia7506381► Subscribe
Canada1180277► Subscribe
German Democratic Republic201974► Subscribe
Germany3033919► Subscribe
Germany3161838► Subscribe
Denmark154326► Subscribe
Denmark396381► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus